allogenic stem cell therapy (Reostem)

N/A

Report date: 2025/03/14 16:27:36

Base Information

Drug Nameallogenic stem cell therapy (Reostem)
Drug Alias NamePre-Morula stem cells therapy
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesReoStem LLC
China Registration ClassN/A

Develop Information

Active CompaniesReoStem LLC
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A